Our
team
Bruno Rasmussen
CMO
Bruno Rasmussen Chaves, is a doctor, graduated and specialised in Clinical Medicine and Gastroenterology, and has been studying ibogaine for over 25 years. He has followed more than two thousand treatments with this substance and intends to help with his work to fully regulate ibogaine treatments in Brazil. He is co-founder and former director of GITA, the Global Ibogaine Therapists Alliance and one of the authors of the article “Treating drug dependence with the aid of ibogaine: a retrospective study”, published in 2014. His work influenced the regulation of hospital use of this medication by the Drug Policy Council of the State of São Paulo. He is currently involved with a new clinical protocol on the long-term effects of ibogaine on crack and cocaine addiction, including studies on his cardiac risks and other research in the area of psychedelic medicine, such as the treatment of PTSD with MDMA, a subject on which recently published research in the Brazilian Journal of Psychiatry.
Bruno Rasmussen Chaves, is a doctor, graduated and specialised in Clinical Medicine and Gastroenterology, and has been studying ibogaine for over 25 years. He has followed more than two thousand treatments with this substance and intends to help with his work to fully regulate ibogaine treatments in Brazil. He is co-founder and former director of GITA, the Global Ibogaine Therapists Alliance and one of the authors of the article “Treating drug dependence with the aid of ibogaine: a retrospective study”, published in 2014. His work influenced the regulation of hospital use of this medication by the Drug Policy Council of the State of São Paulo. He is currently involved with a new clinical protocol on the long-term effects of ibogaine on crack and cocaine addiction, including studies on his cardiac risks and other research in the area of psychedelic medicine, such as the treatment of PTSD with MDMA, a subject on which recently published research in the Brazilian Journal of Psychiatry.